查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1595417

就地检验市场：按产品、最终用户划分 - 2025-2030 年全球预测

Point of Care Testing Market by Product (Cardio-Metabolic Monitoring Kits, Cholesterol Test Strips, Fertility & Pregnancy Testing Kits), End-User (Ambulatory Care, Home Care, Hospitals or Critical Care) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年，就地检验市场价值为289亿美元，预计到2024年将达到325.6亿美元，复合年增长率为12.75%，到2030年将达到669.8亿美元。

就地检验(POCT) 包括在患者护理点或附近进行的医疗诊断测试，并立即记录结果，从而实现快速临床管理决策。 POCT 的需求在于它可以简化疾病管理、缩短住院时间并减轻中心实验室的负担，满足随着慢性病日益普及而日益增长的快速诊断需求。 POCT 具有广泛的应用范围，从糖尿病管理、传染病检查、心血管诊断到重症患者监护和妊娠检测，在医院、诊所和居家医疗环境中至关重要。市场成长是由小型化、更高精度、与医疗 IT 系统整合等技术进步以及医疗消费者倡导自我测试的日益增长趋势所推动的。然而，它面临着严格的法律规范、与传统实验室测试相比更高的测试单位成本以及由于操作员错误和培训不足而导致的可变结果等挑战，这些可能会阻碍市场成长。

主要市场统计
基准年[2023] 289亿美元
预测年份 [2024] 325.6亿美元
预测年份 [2030] 669.8亿美元
复合年增长率（%） 12.75%

市场的创新路径包括整合人工智慧和机器学习以提高诊断准确性和即时监测能力，开拓同时处理多项测试的多功能设备，以及扩展远距远端医疗功能的无线或与智慧型手机相容的设备。公司也应投资扩大在集中医疗设施有限的新兴市场进行慢性病管理的 POCT。为了实现最佳市场定位，相关人员应建立伙伴关係以推动研发进步，并寻求与医疗保健提供者建立策略联盟，以推动服务提供的改进。认识到市场的高度竞争和敏感性质，鼓励相关人员专注于开拓具有成本效益的解决方案、提高测试准确性和易于使用的介面。儘管存在监管挑战和成本障碍，但设备差异化和业务效率的持续创新需求推动了临床和家庭环境中对快速诊断测试的需求不断增长，这带来了强劲的成长机会。

市场动态：揭示快速发展的就地检验的关键市场洞察

供需的动态交互作用正在改变就地检验市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 世界各地慢性病和感染疾病的发生率不断上升
    • 政府政策利好采用POC测试
    • 透过新的先进检测套组加强以患者为中心的护理的潜在需求
  • 市场限制因素
    • 产品开发成本较高
  • 市场机会
    • 厂商研发投入快速增加
    • POC 测试的技术进步
  • 市场问题
    • 监管政策需要时间来核准POC检测套组

波特五力：驾驭就地检验市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解就地检验市场的外部影响

外部宏观环境因素在塑造就地检验市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析：了解就地检验市场的竞争格局

对就地检验市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：就地检验市场供应商的绩效评估

FPNV定位矩阵是评估就地检验市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製就地检验市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对就地检验市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1.市场渗透率：对当前市场环境的详细审查，主要企业的广泛资料，评估他们在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球慢性病和感染疾病的发生率正在增加
      • 政府对POC测试的利多政策介绍
      • 透过新的先进检测套组加强以患者为中心的护理的潜在需求
    • 抑制因素
      • 产品开发成本较高
    • 机会
      • 厂商研发投入快速增加
      • POC 测试的技术进步
    • 任务
      • 监管政策需要时间来核准POC检测套组
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章就地检验市场：依产品

  • 介绍
  • 心臟代谢监测套件
  • 胆固醇试纸
  • 不孕/妊娠检测套组
  • 血糖值监测套件
  • 血液检测套组
  • 传染病检查套件

第七章就地检验

  • 介绍
  • 门诊治疗
  • 居家医疗
  • 医院或加护病房
  • 门诊医疗
  • 研究所

第八章美洲就地检验市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太就地检验市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东和非洲的就地检验市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • Alere Inc
  • Ativa Medical Corporation
  • Becton, Dickinson, and Company
  • BIOMERIEUX SA
  • Chembio Diagnostics
  • Danaher Corporation
  • EKF Diagnostics Holdings plc
  • Henry Schein, Inc
  • Informa PLC
  • Instrumentation Laboratory Company
  • Johnson and Johnson Service, Inc.
  • Medtronic plc
  • Polymer Technology Systems, Inc.
  • QIAGEN GmbH
  • Roche Holding AG
  • Siemens AG
  • Sienco, Inc.
  • WerfenLife, SA
Product Code: MRR-035AB9C0DA8B

The Point of Care Testing Market was valued at USD 28.90 billion in 2023, expected to reach USD 32.56 billion in 2024, and is projected to grow at a CAGR of 12.75%, to USD 66.98 billion by 2030.

Point of Care Testing (POCT) encompasses medical diagnostic testing at or near the site of patient care, offering immediate results that enable rapid clinical management decisions. The necessity for POCT lies in its potential to enhance disease management efficiencies, reduce hospital stays, and alleviate the pressure on centralized laboratories, thus catering to the increasing demand for rapid diagnostics amidst a growing prevalence of chronic diseases. POCT applications range from diabetes management, infectious disease testing, and cardiovascular diagnostics to critical care and pregnancy testing, vital across hospitals, clinics, and home care settings. Market growth is propelled by technological advancements such as miniaturization, superior accuracy, integration with health IT systems, along with a rising healthcare consumerism trend advocating for self-testing. However, the market faces challenges like stringent regulatory frameworks, higher costs per test compared with traditional lab tests, and variability in results due to operator error or inadequate training, which can impede growth.

KEY MARKET STATISTICS
Base Year [2023] USD 28.90 billion
Estimated Year [2024] USD 32.56 billion
Forecast Year [2030] USD 66.98 billion
CAGR (%) 12.75%

Innovative pathways in the market include the integration of artificial intelligence and machine learning to enhance diagnostic accuracy and real-time monitoring capabilities, development of multifunctional devices to process multiple tests concurrently, and wireless or smartphone-compatible devices expanding telehealth capabilities. Companies should also capitalize on expanding POCT for chronic conditions management in emerging markets where access to centralized healthcare facilities is limited. For optimal market positioning, stakeholders should engage in partnerships for R&D advancements and seek strategic alliances with healthcare providers to facilitate service delivery improvements. Recognizing the market's nature as highly competitive and influenced by technological progressions, stakeholders are recommended to focus on cost-effective solutions, increased test precision, and user-friendly interface development. Despite regulatory challenges and cost barriers, the increasing demand for rapid diagnostic tests in clinical and home settings presents a robust growth opportunity, underlined by a necessity for continuous innovation in device differentiation and operational efficiency.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Point of Care Testing Market

The Point of Care Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidence of chronic and infectious diseases globally
    • Favorable government policies for introduction of POC testing
    • Potential demand for enhanced patient-centric care with new advanced testing kits
  • Market Restraints
    • Relatively high cost involved in product development
  • Market Opportunities
    • Surge in research and development investment by manufacturers
    • Technological advancements in POC testing
  • Market Challenges
    • Time-consuming regulatory policies for approval of POC testing kits

Porter's Five Forces: A Strategic Tool for Navigating the Point of Care Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Point of Care Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Point of Care Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Point of Care Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Point of Care Testing Market

A detailed market share analysis in the Point of Care Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Point of Care Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Point of Care Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Point of Care Testing Market

A strategic analysis of the Point of Care Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Point of Care Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACON Laboratories, Inc., Alere Inc, Ativa Medical Corporation, Becton, Dickinson, and Company, BIOMERIEUX SA, Chembio Diagnostics, Danaher Corporation, EKF Diagnostics Holdings plc, Henry Schein, Inc, Informa PLC, Instrumentation Laboratory Company, Johnson and Johnson Service, Inc., Medtronic plc, Polymer Technology Systems, Inc., QIAGEN GmbH, Roche Holding AG, Siemens AG, Sienco, Inc., and WerfenLife, S.A..

Market Segmentation & Coverage

This research report categorizes the Point of Care Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Cardio-Metabolic Monitoring Kits, Cholesterol Test Strips, Fertility & Pregnancy Testing Kits, Glucose Monitoring Kits, Haematology Testing Kits, and Infectious Disease Testing Kits.
  • Based on End-User, market is studied across Ambulatory Care, Home Care, Hospitals or Critical Care, Outpatient Healthcare, and Research Laboratories.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence of chronic and infectious diseases globally
      • 5.1.1.2. Favorable government policies for introduction of POC testing
      • 5.1.1.3. Potential demand for enhanced patient-centric care with new advanced testing kits
    • 5.1.2. Restraints
      • 5.1.2.1. Relatively high cost involved in product development
    • 5.1.3. Opportunities
      • 5.1.3.1. Surge in research and development investment by manufacturers
      • 5.1.3.2. Technological advancements in POC testing
    • 5.1.4. Challenges
      • 5.1.4.1. Time-consuming regulatory policies for approval of POC testing kits
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Point of Care Testing Market, by Product

  • 6.1. Introduction
  • 6.2. Cardio-Metabolic Monitoring Kits
  • 6.3. Cholesterol Test Strips
  • 6.4. Fertility & Pregnancy Testing Kits
  • 6.5. Glucose Monitoring Kits
  • 6.6. Haematology Testing Kits
  • 6.7. Infectious Disease Testing Kits

7. Point of Care Testing Market, by End-User

  • 7.1. Introduction
  • 7.2. Ambulatory Care
  • 7.3. Home Care
  • 7.4. Hospitals or Critical Care
  • 7.5. Outpatient Healthcare
  • 7.6. Research Laboratories

8. Americas Point of Care Testing Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Point of Care Testing Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Point of Care Testing Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. ACON Laboratories, Inc.
  • 3. Alere Inc
  • 4. Ativa Medical Corporation
  • 5. Becton, Dickinson, and Company
  • 6. BIOMERIEUX SA
  • 7. Chembio Diagnostics
  • 8. Danaher Corporation
  • 9. EKF Diagnostics Holdings plc
  • 10. Henry Schein, Inc
  • 11. Informa PLC
  • 12. Instrumentation Laboratory Company
  • 13. Johnson and Johnson Service, Inc.
  • 14. Medtronic plc
  • 15. Polymer Technology Systems, Inc.
  • 16. QIAGEN GmbH
  • 17. Roche Holding AG
  • 18. Siemens AG
  • 19. Sienco, Inc.
  • 20. WerfenLife, S.A.

LIST OF FIGURES

  • FIGURE 1. POINT OF CARE TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. POINT OF CARE TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES POINT OF CARE TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES POINT OF CARE TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. POINT OF CARE TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. POINT OF CARE TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. POINT OF CARE TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. POINT OF CARE TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY CARDIO-METABOLIC MONITORING KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY CHOLESTEROL TEST STRIPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY FERTILITY & PREGNANCY TESTING KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY GLUCOSE MONITORING KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY HAEMATOLOGY TESTING KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY INFECTIOUS DISEASE TESTING KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY HOSPITALS OR CRITICAL CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY OUTPATIENT HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES POINT OF CARE TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. AUSTRALIA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. AUSTRALIA POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. CHINA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. CHINA POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. INDIA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. INDIA POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. INDONESIA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. INDONESIA POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. JAPAN POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. JAPAN POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. MALAYSIA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. MALAYSIA POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. PHILIPPINES POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. PHILIPPINES POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. SINGAPORE POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. SINGAPORE POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. SOUTH KOREA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. SOUTH KOREA POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. TAIWAN POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. TAIWAN POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. THAILAND POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. THAILAND POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. VIETNAM POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. VIETNAM POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. DENMARK POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. DENMARK POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. EGYPT POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. EGYPT POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. FINLAND POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. FINLAND POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. FRANCE POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. FRANCE POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. GERMANY POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. GERMANY POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. ISRAEL POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. ISRAEL POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. ITALY POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. ITALY POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. NETHERLANDS POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. NETHERLANDS POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. NIGERIA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. NIGERIA POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. NORWAY POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. NORWAY POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. POLAND POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. POLAND POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. QATAR POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. QATAR POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. RUSSIA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. RUSSIA POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. SAUDI ARABIA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. SAUDI ARABIA POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH AFRICA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH AFRICA POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. SPAIN POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. SPAIN POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. SWEDEN POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. SWEDEN POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. SWITZERLAND POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. SWITZERLAND POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. TURKEY POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. TURKEY POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED ARAB EMIRATES POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED ARAB EMIRATES POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED KINGDOM POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. UNITED KINGDOM POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. POINT OF CARE TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 107. POINT OF CARE TESTING MARKET, FPNV POSITIONING MATRIX, 2023